Illumina, Inc. ILMN
270.00
(3.90)
(1.42%)
as of 25 Sep
- Market cap
- $41.3B
- P/E
- 50.4×
Follow ILMN
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Illumina, Inc. (ILMN) Debt to equity
Illumina, Inc.'s debt to equity at the end of the quarter to 30 June 2026 was 0.5×, down 0.0× from fiscal 2025 (0.5×). Over the past ten years it has ranged from 0.2× (fiscal 2021) to 0.6× (fiscal 2024); the current reading is higher than 82% of that period. That is above the Diagnostics & Research industry median of 0.1× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Annual
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 0.5× | (12.85%) |
| FY2024 | 0.6× | 142.25% |
| FY2023 | 0.3× | (39.15%) |
| FY2022 | 0.4× | 159.12% |
| FY2021 | 0.2× | (34.81%) |
| FY2020 | 0.3× | (1.91%) |
| FY2019 | 0.3× | (50.50%) |
| FY2018 | 0.5× | 19.79% |
| FY2017 | 0.4× | (6.97%) |
| FY2016 | 0.5× | (21.00%) |
Quarterly
| Period | Debt to equity | Change |
|---|---|---|
| Jun 2026 | 0.5× | (5.64%) |
| Mar 2026 | 0.6× | 1.75% |
| Dec 2025 | 0.5× | 31.07% |
| Sep 2025 | 0.4× | (36.82%) |
| 42 more quarters | Free account |
Against its own ten years
Low 0.2×
High 0.6×
Ten-year median
0.4×
Current reading's percentile
82
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| GH Guardant Health, Inc. compare | −6.7× |
| NTRA Natera, Inc. compare | 0.0× |
| IDXX IDEXX Laboratories, Inc. compare | 0.3× |
| WAT Waters Corporation compare | 0.3× |
| A Agilent Technologies, Inc. compare | 0.5× |
| ILMN Illumina, Inc. | 0.5× |
| DGX Quest Diagnostics Incorporated compare | 0.7× |
| IQV IQVIA Holdings Inc. compare | 2.5× |
| MTD Mettler-Toledo International, Inc. compare | 165× |
| Diagnostics & Research industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.2× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on ILMN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement